Latest news

Erasmus MC will receive over 7 million euros in research funds from the Horizon Europe initiative. The money will go to six projects, two of which are coordinated by Erasmus MC scientists. The topics range from psychiatry to oncology.

Administration of the antithrombotic drugs acetylsalicylic acid (aspirin) or heparin during catheter treatment of stroke patients leads to an increased risk of intracerebral hemorrhage, with no beneficial effect on recovery. This has been shown by research coordinated by Erasmus MC.

The Erasmus MC will work closely with the European Medicines Agency on the establishment of the Coordination Centre for the Data Analysis and Real World Interrogation Network (DARWIN EU®).

Nico Bruining and his team are the go-to people in the Erasmus MC for anything that has to do with computers and cardiology. Artificial intelligence has given their discipline a boost. ‘We build the technology of tomorrow, which we would have liked to have yesterday.’

Molecular radiation biologist Dr. Julie Nonnekens and developmental psychologist Dr. Charlotte Cecil have both been granted a Starting Grant from the European Research Council (ERC). With the prestigious grant the young scientists of Erasmus MC can expand their research projects.

The coronavirus SARS-CoV-2 infects kidney cells and contributes to tissue scarring in the kidneys. This has been shown by researchers from the Erasmus MC, RWTH Uniklinik Aachen in Germany and Radboudumc.

Around 30 percent fewer strokes were diagnosed during the first corona wave than during similar periods in previous years. The number of heart attacks diagnosed remained the same. This is evident from research conducted by the Erasmus MC in the Rotterdam Rijnmond region.

Erasmus MC will join five European Reference Networks (ERNs) for complex and rare diseases as of January 1, 2022. This will make Erasmus MC a participant in 23 of the 24 existing networks.